top of page
Search
How to Read Peptide COA Results Before You Buy

How to Read Peptide COA Results Before You Buy

Nathan Marks
Aug 19
5 min read

A peptide certificate of analysis is not a marketing attachment. It is a batch-specific quality document that should help you determine whether the material in front of you matches the material described. Knowing how to read peptide COA results protects research continuity, reduces procurement risk, and makes it easier to distinguish meaningful analytical data from generic claims.

A credible COA does not need to be complicated. It does need to be traceable, method-aware, and connected to the exact lot you are evaluating. Purity alone is not the full story. Identity, method details, reporting limits, and document controls matter just as much.

Start With Lot Traceability

Read the top of the COA before looking at the purity figure. The product name, catalog identifier, batch or lot number, manufacture date, retest or expiration date, and report date should be clear. Most importantly, the lot number on the COA must match the lot number on the vial, outer packaging, or shipment record.

A COA that shows only a product name, such as “BPC-157” or “Tesamorelin,” is not sufficient evidence for a specific batch. One product may be manufactured across multiple lots, and analytical results can vary from lot to lot. A vendor should be able to provide documentation tied to the material actually supplied.

Also check whether the document identifies the testing laboratory or quality unit. That may include the laboratory name, analyst or reviewer initials, a report number, and approval date. These controls do not prove that every result is accurate, but their absence makes verification difficult.

How to Read Peptide COA Identity Results

Identity answers a basic question: is the tested material consistent with the intended peptide? For synthetic peptides, identity is commonly supported by mass spectrometry, often shown as MS, LC-MS, or MALDI-TOF MS.

The COA may list a theoretical molecular weight alongside an observed molecular weight. These values should be reasonably aligned, accounting for the analytical method, ionization state, salt form, and expected adducts. Peptides frequently appear in multiple charged states during mass spectrometry, so the spectrum may show several peaks rather than one simple molecular-weight value.

Do not assume that a matching mass alone confirms complete identity. Mass spectrometry can support the expected molecular weight, but some sequence-related impurities or structurally similar species may require additional characterization to distinguish. This is why identity data should be reviewed alongside chromatographic purity and, where appropriate, higher-level characterization such as peptide mapping or amino acid analysis.

If a COA simply states “passes identity” without naming a method or providing an observed result, treat that as limited evidence. The phrase may reflect an internal specification, but it does not tell you what was measured or how closely the result matched the target.

Understand What the Purity Number Means

Most peptide COAs report purity through high-performance liquid chromatography, usually HPLC or UPLC. A result such as “99.1% by HPLC” generally means that the primary chromatographic peak accounts for 99.1% of the integrated signal under the stated test conditions.

That is useful, but it is not automatically the same as 99.1% peptide content by weight. Chromatographic area percent measures the relative response of detected peaks. It may not fully account for water, residual counterions, inorganic salts, or compounds that do not respond the same way under the detector conditions.

Look for three pieces of information: the reported purity percentage, the method used, and the chromatogram. A chromatogram should show a dominant main peak and disclose meaningful secondary peaks. The report should ideally identify the column, mobile phases, detection wavelength, run time, and integration approach. More method context means more confidence that the result can be interpreted rather than merely repeated.

Purity expectations depend on the research application. A material suitable for early analytical work may be assessed differently from material needed for sensitive assay development or controlled comparative studies. The right question is not always “Is the number above 99%?” It is “Does the available characterization support this material for the work planned?”

Separate Purity From Peptide Content

This distinction is commonly missed. Purity describes the relative composition of detected material. Peptide content, sometimes called net peptide content or assay, addresses how much actual peptide is present after accounting for associated water, salts, counterions, or other non-peptide mass.

For example, a lyophilized peptide may be reported as highly pure by HPLC while still containing water or a counterion such as trifluoroacetate or acetate. This does not necessarily indicate poor quality. It does affect calculations when work requires precise molar concentration or mass balance.

A strong COA or supporting quality package may include peptide content, water content by Karl Fischer analysis, and counterion information. If those values are not available, do not infer them from the HPLC purity result. Build your research calculations around the documentation provided and validate critical concentrations in-house when the application warrants it.

Review Residuals and Application-Relevant Tests

Residual solvent results can be valuable because peptide synthesis and purification may involve organic solvents. A COA may list solvents such as acetonitrile, methanol, dichloromethane, or dimethylformamide, along with measured values and specification limits. Results reported as “not detected” should include a detection or quantitation limit when possible. Without that limit, the phrase provides less context.

Other tests may appear depending on the product and its intended research setting. These can include water content, microbial limits, bioburden, endotoxin, appearance, pH, or elemental impurity screening. Not every test is necessary for every research-grade peptide, and a longer COA is not automatically a better one.

The relevant standard depends on the use case. Analytical research, cell-based assays, and highly sensitive biological systems may require different controls. Request data that matches the risk profile of the experiment rather than relying on a fixed checklist for every compound.

Check the Specification Against the Result

A COA should show both the specification and the actual result. “Purity: 99.3%” is less informative than “Purity by HPLC: not less than 98.0%; result: 99.3%.” The second format shows whether the batch met a defined release criterion.

Pay attention to units. Residual solvents may be listed in parts per million, water in percentage by weight, endotoxin in EU/mg, and peptide content as a percentage or mass value. A result without units cannot be evaluated reliably.

Be cautious with perfect-looking reports. Exact round numbers, missing analytical conditions, duplicate COAs across supposedly different lots, or a single generic document reused for every product are all reasons to ask more questions. Quality documentation should reflect actual testing, not just a template.

Questions Worth Asking Before Procurement

When the COA leaves uncertainty, ask for clarification before placing material into a study. A disciplined supplier should be able to address practical questions such as:

  • Is this COA tied to the exact lot being shipped?

  • Which method was used for identity and purity testing?

  • Is the stated result a chromatographic purity value, peptide content value, or both?

  • Are chromatograms, spectra, and method details available for review?

  • What are the reporting limits for residuals listed as not detected?

The answer matters as much as the document. Clear, specific responses indicate that quality records are being managed as part of the supply process. Vague assurances do not replace lot-level data.

What a COA Cannot Tell You

A COA is essential, but it is not a complete substitute for supplier qualification or internal verification. It cannot independently establish how a product was stored after release, whether it was handled correctly during transit, or whether it remains fit for a highly specialized method in your laboratory.

Likewise, a reference to cGMP manufacturing is valuable only when supported by relevant documentation and appropriate controls. Manufacturing standards, analytical release testing, packaging integrity, storage practices, and domestic fulfillment all contribute to material confidence. No compromises. No shortcuts.

For research use, treat the COA as the starting point for an evidence-based purchasing decision. Match the lot, read the methods behind the headline number, and ask for data that fits your experiment. The best COA is not the one with the biggest purity claim. It is the one that gives your laboratory a clear, traceable basis to proceed.

 
 
 

Comments


bottom of page